Drug Information

Drug General Information
Drug ID
D07FDL
Former ID
DNC012519
Drug Name
N-(2,3-Dihydro-1H-phenalen-2-yl)-acetamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534186]
Formula
C15H15NO
Canonical SMILES
CC(=O)NC1CC2=CC=CC3=C2C(=CC=C3)C1
InChI
1S/C15H15NO/c1-10(17)16-14-8-12-6-2-4-11-5-3-7-13(9-14)15(11)12/h2-7,14H,8-9H2,1H3,(H,16,17)
InChIKey
NSODBKSYAOTJPJ-UHFFFAOYSA-N
PubChem Compound ID
9859366
Target and Pathway
Target(s) Melatonin receptor Target Info Inhibitor [534186]
KEGG Pathway Neuroactive ligand-receptor interaction
Circadian entrainment
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 534186J Med Chem. 1996 Aug 2;39(16):3089-95.Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Ref 534186J Med Chem. 1996 Aug 2;39(16):3089-95.Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.